Stock INDP INDAPTUS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Indaptus Therapeutics, Inc.

Equities

INDP

US45339J1051

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
2.49 USD +2.05% Intraday chart for Indaptus Therapeutics, Inc. -10.75% +41.48%
Mar. 14 Top Premarket Gainers MT
Mar. 13 Indaptus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Indaptus Therapeutics, Inc.

6f12c16a5c.aYByGawDSfmiRe9_pCAktUqLcW_zzht8yowWJX59w9U.A-oRa9pJAKbTIcI47RFAhn34PQakuW8zm8V4dgoH8qAKwjsh7ToAsMV3iA~db6543bba491c8c178ae0bc5a1975b06

Upcoming events on Indaptus Therapeutics, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-04 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-12 Q4 2024 Earnings Release (Projected)

Past events on Indaptus Therapeutics, Inc.

2024-04-09 American Association for Cancer Research Meeting
2024-04-03 09:55 am MedInvest Biotech & Pharma Investor Conference
2024-03-13 07:30 am Q4 2023 Earnings Release
2024-02-26 10:45 am BIO CEO & Investor Conference
2023-11-06 04:01 pm Q3 2023 Earnings Release
2023-11-03 Society for Immunotherapy of Cancer Meeting
2023-10-03 03:30 pm LD Micro Main Conference
2023-09-29 11:30 am Tribe Public CEO Conference
2023-09-13 08:30 am H.C. Wainwright Global Investment Conference
2023-08-14 08:00 am Q2 2023 Earnings Release
2023-06-21 10:30 am Maxim Group Virtual Healthcare Conference
2023-06-09 08:00 am Jefferies Healthcare Conference
2023-05-25 10:00 am Annual General Meeting
2023-05-11 02:30 pm STING & TLR-Targeting Therapies Summit
2023-05-11 07:00 am Q1 2023 Earnings Release
2023-05-10 01:30 pm STING & TLR Targeting Therapies Summit
2023-04-26 02:30 pm Planet MicroCap Showcase
2023-04-18 09:00 am American Association for Cancer Research Meeting - Abstract #4165
2023-03-29 10:00 am Investor Summit Conference
2023-03-17 08:00 am Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-7,73
-18,8
58.98%		-14,9
-15,5
3.64%		-16,4
-16,8
2.63%
-21,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-7,71
-18,9
59.2%		-14,3
-15,3
6.57%		-15,4
-16,3
5.59%
-21,1

Net income
Million USD		Released
Forecast
Spread 		-3,58


-7,71
-18,9
59.27%		-14,3
-15,3
6.57%		-15,4
-16,3
5.59%
-21,1

EPS
USD		Released
Forecast
Spread 		-4,89


-1,89
-6,16
69.29%		-1,73
-1,94
10.82%		-1,83
-1,90
3.68%
-2,00

Announcement Date20/04/2121/03/2217/03/2313/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-3,22
-3,91
17.74%		-3,40
-3,20
-6.31%		-3,87
-3,80
-1.82%		-3,55
-4,20
15.42%		-4,09
-4,65
12.11%		-4,46
-4,95
9.93%		-3,50
-4,90
28.68%		-4,25
-4,46
4.84%		-4,18
-4,62
9.57%
-4,90


-5,10


-5,30


-5,50

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-3,22
-3,91
17.67%		-3,37
-3,19
-5.49%		-3,84
-3,80
-0.93%		-3,47
-4,20
17.47%		-3,66
-4,64
21.28%		-4,25
-4,94
13.93%		-3,25
-4,90
33.73%		-3,92
-4,40
10.84%		-4,00
-4,53
11.58%
-4,83


-5,05


-5,03


-5,29

Net income
Million USD		Released
Forecast
Spread 		-3,22
-3,91
17.67%		-3,37
-3,19
-5.49%		-3,84
-3,80
-0.93%		-3,47
-4,20
17.47%		-3,66
-4,64
21.28%		-4,25
-4,94
13.93%		-3,25
-4,90
33.73%		-3,92
-4,40
10.84%		-4,00
-4,53
11.58%
-4,83


-5,05


-5,03


-5,29

EPS
USD		Released
Forecast
Spread 		-0,22
-0,90
75.56%		-0,41
-0,39
-5.13%		-0,46
-0,91
49.45%		-0,42
-0,51
17.65%		-0,44
-0,45
2.22%		-0,51
-0,50
-3.03%		-0,39
-0,58
32.76%		-0,47
-0,52
9.62%		-0,47
-0,54
12.96%
-0,57


-0,60


-0,42


-0,34

Announcement Date21/03/2212/05/2208/08/2210/11/2217/03/2311/05/2314/08/2306/11/2313/03/24----

Upcoming sector events for Indaptus Therapeutics, Inc.

Today 01:45 am ADDLIFE AB: Q1 2024 Earnings Release
2024-04-24 PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release
2024-04-24 SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release
2024-04-24 HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release
2024-04-24 PURETECH HEALTH PLC: Q4 2023 Earnings Release
2024-04-25 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
2024-04-25 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
More events

Past sector events for Indaptus Therapeutics, Inc.

Today SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release
Today MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected)
Today CUREVAC N.V.: Q4 2023 Earnings Release
Today ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release
Today EVOTEC SE: Q4 2023 Earnings Release
2024-04-22 SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected)
2024-04-22 HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q1 2024 Earnings Release
2024-04-22 HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2023 Earnings Release
2024-04-22 04:15 pm MEDPACE HOLDINGS, INC.: Q1 2024 Earnings Release
2024-04-17 02:07 am TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. INDP Stock
  4. Calendar Indaptus Therapeutics, Inc.